GT Biopharma Inc reports results for the quarter ended in March - Earnings Summary

GT Biopharma

16/05/2022 22:02

* GT Biopharma Inc  GTBP.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 31 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * GT Biopharma Inc's reported EPS for the quarter was a loss
of 17
cents​.
    * The mean earnings estimate of analysts had fallen by
about 36.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * GT Biopharma Inc shares had fallen by 33.0% this
quarter and
lost 36.7% so far this year.
    * The company reported a quarterly loss of $5.44 million.
    * Wall Street's median 12-month price target for GT
Biopharma Inc
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated